Navigation Links
Sunnylife Global Announces Completion of Surgical Wing of Xiang Tan World Friendship Hospital
Date:1/29/2008

SURGICAL WING OPENED JANUARY 15, 2008

LOS ANGELES, Jan. 29 /PRNewswire-FirstCall/ -- Sunnylife Global, Inc. (Pink Sheets: SNYL) announced today that, on January 8, 2008, the renovation of Xiang Tan World Friendship Hospital was officially completed and approved by the Xiang Tan City Government. Under the management of Sunnylife Global, Inc. and hospital staff, the Xiang Tan World Friendship Hospital was renovated in accordance with international standards.

On January 15, 2008, all in-patients of the surgery department as well as those in the gynecological and obstetrical department were transferred to the new building.

The surgical building comprises 126 movable hospital beds and four sterile operating rooms that are the most advanced in Hunan Province. The surgery building features dependable elevators, a central air-conditioning system, a central oxygen supply system, an intensive care unit, and networked computerized environmental controls. With its esthetically pleasing environment and ability to handle surgical procedures in a timely manner, this surgery building becomes one of the best in Xiang Tan City.

The Hunan Government and its national capital committee have provided their full support for this important project. Under the sponsorship, guidance, and support of Sunnylife Global, Inc., Xiang Tan World Friendship Hospital is well on its way to becoming one of the best hospitals in Hunan Province. This project also represents a new paradigm in cooperation between the China and the U.S. in the field of healthcare.

About Sunnylife Global

Sunnylife Global, Inc. is the only foreign company authorized by the PRC central government to acquire, control, and operate existing Level 2 private hospitals in the PRC. To date, the Company has concluded 21 Letters of Intent relating to such hospitals, nine of which have moved to the contract stage or beyond. All of the nine have been fully approved by the requisite departments of the local, regional, and central governments. Renovation and modernization of two of the nine has been started and is at varying stages of completion. This program, aimed at creating a hospital chain or network, is part of the PRC's initiative to upgrade their Level 2 hospitals (those with 250-500 beds, of which there are more than 10,000 in the PRC) to international standards. The Company is arranging the financing for the renovation of the first two hospitals.

Hospitals owned and managed by Sunnylife will derive their revenues principally from a health-care plan known as a Healthcare Management System (similar to an HMO). Each HMS typically has about 50,000 members and receives fees of $375 - $425 per member per year. Enrollment has begun. Because they function within a more predictable cost environment (i.e., professionals, support staff, pharmaceuticals, insurance, etc.), hospitals within the PRC typically have higher operating margins than hospitals in the West.

The Company has plans to build and operate several assisted-living centers, each providing for the needs of approximately 3,000 people. The PRC government has committed to contributing the real estate required for these assisted-living facilities. The initial two plots have been designated, each of which covers 82 acres. Financing for construction of the first assisted- living facility has been committed. More than 46,000 people have pre-applied for the first assisted-living facility. The assisted-care industry in the PRC is expected to grow to one of the largest industries in the world over the next 20 years.

The above news release contains forward-looking statements. These statements are based on assumptions that management believes are reasonable based on currently available information, and include statements regarding the intent, belief or current expectations of the Company and its management. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and are subject to a wide range of business risks, external factors and uncertainties. Actual results may differ materially from those indicated by such forward-looking statements. For additional information, please consult the Company's most recent public filings and 10-K. The Company assumes no obligation to update the information contained in this press release, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Sunnylife Global, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Global Experts Explore Entire Spectrum of Aids Vaccine Development
2. Mindray to Present at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
3. Advanced Life Sciences to Present at 2007 UBS Global Life Sciences Conference
4. Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health
5. Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
6. Clinsys Clinical Research, Inc. Announces Key Hires, Rajagopalan Srinivasan, Ph.D, to Strengthen Global Biostatistics Service Offering and Christopher Gregory, Ph.D, to Scientific Affairs
7. Jazz Pharmaceuticals to Present at UBS Global Life Sciences Conference
8. A Large-Scale Research Project by a Dutch Consortium Addressing a Global Problem
9. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
10. Allos Therapeutics to Present at the 2007 UBS Global Life Sciences Conference
11. Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference to Webcast Millennium Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Research and Markets has announced the ... to their offering. ... The Global Market for Bioproducts Should Reach ... a CAGR of 8.9%, This research report ... seven major product segments: bio-derived chemicals, biofuels, pharmaceuticals (biodrugs and ...
(Date:3/23/2017)... PARK, Calif., March 23, 2017  BioPharmX Corporation ... products for the dermatology market, today reported financial ... 31, 2017, and will provide an update on ... the year. "We are pleased to ... year for BioPharmX," said President Anja Krammer. "We ...
(Date:3/23/2017)... , March 23, 2017 According to a ... and derivatives market is fragmented due to the presence of a large ... Proliant, Thermo Fisher , and Sigma-Aldrich, compete with each other ... companies, collectively, held more than 76% of this market in 2016.  ... As of now, ...
(Date:3/22/2017)... , March 22, 2017 Regeneron Pharmaceuticals, Inc. ... Regeneron Genetics Center (RGC), U.K. Biobank and GSK to generate ... U.K. Biobank resource. The initiative will enable researchers to gain ... medicines for a wide range of serious and life threatening ... ...
Breaking Biology Technology:
(Date:3/2/2017)... , March 2, 2017 Summary ... better understand Merck KGaA and its partnering interests and ... https://www.reportbuyer.com/product/3605601/ Description The Partnering Deals and Alliance ... partnering activity of one of the world,s leading life ... prepared upon purchase to ensure inclusion of the most ...
(Date:2/28/2017)... , February 28, 2017 News solutions ... ... Amsterdam from 14 to 16 March, Materna will ... and show how seamless travel is a real benefit for passengers. ... added biometrics to their passenger touch point solutions to take passengers ...
(Date:2/22/2017)... LONDON , Feb. 22, 2017 ... by 2021, ABI Research identifies four technologies that ... solutions to secure significant share in the changing ... payments, and passive authentication.   "Companies ... it comes to security," says Dimitrios Pavlakis ...
Breaking Biology News(10 mins):